Add BrightSurf on Google Email

Lower prevalence of PSC among patients with IBD in Asia: Insights from a multinational study

A multinational study found PSC prevalence among Asian IBD patients to be markedly lower than in Western countries, associated with more favorable clinical outcomes. The proportion of asymptomatic PSC cases has increased due to improved imaging modality detection, allowing for early-stage diagnosis and reduced liver transplantation rates.

SourceUniversity of Tsukuba·JournalClinical Gastroenterology and Hepatology·DateDec 2, 2025

American Gastroenterological Association streamlines Crohn’s disease treatment guidance as new therapies expand options

The American Gastroenterological Association has released an updated clinical guideline on the pharmacological management of moderate-to-severe Crohn’s disease, recommending early use of high-efficacy therapies to improve patient outcomes. The guideline organizes treatments by efficacy to simplify decision-making for gastroenterologist...

SourceAmerican Gastroenterological Association·JournalGastroenterology·TypeNews article·DateNov 20, 2025

Mount Sinai’s Jean-Frédéric Colombel, MD, to deliver the 31st Anatomy Lesson in Amsterdam, highlighting global efforts to prevent and cure Crohn’s disease

Renowned gastroenterologist Jean-Frédéric Colombel, MD, will deliver the 31st Anatomy Lesson on November 20, exploring Mount Sinai's pioneering work in IBD prevention and treatment. His presentation aims to highlight the growing problem of immune diseases, including Crohn's disease.

Are probiotics worth the cost to prevent infection after a colon removal surgery?

A UCLA Health study found that taking an 8-strain probiotic daily reduces the risk of pouchitis, a common inflammatory condition. However, the treatment's cost-effectiveness depends on the patient's likelihood of flare-ups, with benefits only seen in patients with frequent relapses.

SourceUniversity of California - Los Angeles Health Sciences·JournalGastro Hep Advances·TypeComputational simulation/modeling·DateSep 3, 2025

Unmasking inflammatory bowel disease in nigeria: a multicenter cross-sectional analysis of clinico-pathological and endoscopic findings

This study identifies ulcerative colitis as the most common subtype of IBD in Nigeria, with rectal bleeding being the predominant clinical feature. The findings highlight significant management challenges due to high medication costs and limited availability, affecting nearly half of patients.

SourceXia & He Publishing Inc.·JournalJournal of Translational Gastroenterology·DateAug 27, 2025

AI analysis of colonoscopy improves assessment of Crohn’s disease

A new study published in Clinical Gastroenterology and Hepatology shows that AI analysis can accurately identify mucosal ulceration as well as human reviewers, providing a more objective and reproducible assessment of Crohn's disease. The findings have potential implications for education, drug development, and automated care.

SourceMichigan Medicine - University of Michigan·JournalClinical Gastroenterology and Hepatology·TypeImaging analysis·DateAug 27, 2025

Study suggests no link between antibiotic exposure and autoimmune diseases in children

A large-scale study published in PLOS Medicine found no association between early life antibiotic exposure and the development of autoimmune diseases in children. Researchers analyzed data from over 4 million Korean children and discovered no increased risk of Type 1 diabetes, Juvenile idiopathic arthritis, or other autoimmune conditions.

SourcePLOS·JournalPLOS Medicine·TypeObservational study·DateAug 21, 2025

Interrater reliability of the Nancy Histologic Index in assessing histologic remission in treated ulcerative colitis biopsies: a multi-institutional experience among gastrointestinal pathologists in the United States

The study found substantial interrater reliability for active disease grades, but variability in individual grade assignments. The NHI showed substantial interrater reliability (ICC = 0.79) among US gastrointestinal pathologists for assessing histologic remission in treated ulcerative colitis biopsies.

SourceXia & He Publishing Inc.·JournalJournal of Clinical and Translational Pathology·DateJul 29, 2025

Mount Sinai researchers use wearable technology to explore the link between IBD and sleep disruption

The study found that significant changes in sleep metrics occurred only when inflammation was present in the body, with symptoms alone not resulting in any notable sleep disruption. Sleep disturbances worsened leading up to inflammatory flares and improved afterward, suggesting that sleep changes may signal upcoming disease activity.

SourceThe Mount Sinai Hospital / Mount Sinai School of Medicine·JournalClinical Gastroenterology and Hepatology·DateJun 26, 2025

Oxygen deprivation promotes colon cancer growth

Researchers at The University of Osaka found that localized oxygen deficiency in colon tumors can promote tumor growth by transforming normal fibroblasts into inflammatory fibroblasts. These altered cells release factors that help tumors grow, offering a potential new target for cancer therapy.

SourceThe University of Osaka·JournalNature Communications·TypeExperimental study·DateMay 20, 2025

Research collaboration charts global four-stage evolution of inflammatory bowel disease

Researchers from UCalgary and Chinese University of Hong Kong found that IBD progresses through four predictable epidemiological stages as it spreads globally. The study forecasts a major rise in IBD prevalence in Canada by 2045, with countries in North America, Europe, and Oceania reaching Stage 3 (compounding prevalence). Developing ...

SourceUniversity of Calgary·JournalNature·TypeMeta-analysis·DateApr 30, 2025

Biologists transform gut bacteria into tiny protein pharmacies

Researchers at Virginia Tech have developed a method to convert gut bacteria into mini protein factories that produce and release sustained flows of targeted proteins within the lower intestine. This approach eliminates a major roadblock in delivering drugs to this part of the body, offering potential treatment for chronic diseases.

SourceVirginia Tech·JournalNature·DateFeb 18, 2025

First American Gastroenterological Association living guideline for moderate-to-severe ulcerative colitis

The American Gastroenterological Association (AGA) has released a new clinical guideline on the pharmacological management of moderate-to-severe ulcerative colitis. The guideline groups available treatments into 'efficacy buckets' to facilitate personalized treatment planning, taking into account patient risk factors and disease severity.

SourceAmerican Gastroenterological Association·JournalGastroenterology·DateNov 19, 2024

New study shows how salmonella tricks gut defenses to cause infection

A new UC Davis Health study has uncovered the mechanisms by which Salmonella bacteria evade the body's natural defenses in the gut. The research found that Salmonella alters the gut's nutrient environment to fuel its replication in the large intestine, creating an imbalance that helps the pathogen survive. This new understanding could ...

SourceUniversity of California - Davis Health·JournalProceedings of the National Academy of Sciences·DateNov 15, 2024

Women with premature ovarian insufficiency are at greater risk of severe autoimmune diseases

A large study found that women with premature ovarian insufficiency are 2.6 times more likely to have an autoimmune disorder, with some conditions increasing the risk by 26 times. The study suggests a strong link between POI and severe autoimmune diseases, highlighting the need for medical professionals to be aware of this increased risk.

SourceEuropean Society of Human Reproduction and Embryology·JournalHuman Reproduction·TypeObservational study·DateSep 25, 2024

Scientists identify a unique combination of bacterial strains that could treat antibiotic-resistant gut infections

Researchers have identified 18 beneficial bacterial strains that suppress the growth of harmful bacteria and alleviate inflammation in mouse intestines. The strains compete with harmful bacteria for nutrients, promoting a healthier intestinal microbiome and potentially treating antibiotic-resistant gut infections.

First narrow-spectrum antibiotic successfully eliminates Fusobacterium nucleatum in breakthrough study at the ADA Forsyth institute

A new narrow-spectrum antibiotic, FP 100, has been found to effectively eliminate Fusobacterium nucleatum without harming the oral or gut microbiomes. This breakthrough discovery holds significant implications for treating severe gum disease and preventing related systemic conditions such as colon cancer and Alzheimer's disease.

SourceForsyth Institute·JournalJournal of Oral Microbiology·TypeExperimental study·DateSep 4, 2024

A potential pathway may guide new therapies for inflammatory bowel disease and other inflammatory diseases

Researchers discovered a unique probiotic strain, Bifidobacterium bifidum BB1, that strengthens intestinal barrier function and protects against harmful bacteria. This strain may lead to the development of novel therapies for patients with inflammatory bowel disease and other inflammatory conditions.

SourceElsevier·JournalAmerican Journal Of Pathology·TypeExperimental study·DateAug 22, 2024